Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Bretylium tosylate (substance) |
Is a |
False |
Bretylium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bretylium measurement |
Component |
True |
Bretylium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Bretylium adverse reaction |
Causative agent (attribute) |
True |
Bretylium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to bretylium (finding) |
Causative agent (attribute) |
False |
Bretylium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bretylium overdose (disorder) |
Causative agent (attribute) |
True |
Bretylium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental bretylium overdose |
Causative agent (attribute) |
True |
Bretylium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional bretylium overdose |
Causative agent (attribute) |
True |
Bretylium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Bretylium overdose of undetermined intent |
Causative agent (attribute) |
False |
Bretylium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Bretylium-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bretylium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Breytlium tosylate 50mg/ml injection solution 400mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bretylium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Breytlium tosylate 50mg/ml injection solution 50mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bretylium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Breytlium tosylate 50mg/ml injection solution 200mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bretylium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to bretylium (finding) |
Causative agent (attribute) |
True |
Bretylium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Bretylium tosylate (substance) |
Is modification of (attribute) |
True |
Bretylium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bretylium-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bretylium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Bretylium only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bretylium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Bretylium only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bretylium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely bretylium 50 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Bretylium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely bretylium 50 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Bretylium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |